Song Lan-Gui, Wu Xiao-Ying, Sacko Moussa, Wu Zhong-Dao
Department of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.
Key Laboratory of Tropical Disease Control, Ministry of Education, Guangzhou, Guangdong, China.
Parasitol Res. 2016 Nov;115(11):4071-4081. doi: 10.1007/s00436-016-5253-5. Epub 2016 Sep 28.
Schistosomiasis is a snail-borne disease caused by worms of the genus Schistosoma. Worldwide, human schistosomiasis remains a serious public health problem, threatening ∼800 million people in 78 countries with a loss of 70 million disability-adjusted life years. Schistosoma japonicum is the only human blood fluke that occurs in China. As one of the countries suffering greatly from schistosomiasis, over the past 65 years, China has made great strides in controlling schistosomiasis, blocking the transmission of S. japonicum in five provinces, remarkably reducing transmission intensities in the other seven endemic provinces, and China is currently preparing to move toward the elimination of this disease before 2025. However, while on the road to schistosomiasis elimination, emerging challenges merit attention, including severe advanced cases, increased movements of population and livestock, large-area distribution of intermediate host snails, limitations of new drug developments and no vaccine available, as well as imported schistosomiasis and its potential risk.
血吸虫病是一种由血吸虫属蠕虫引起的经蜗牛传播的疾病。在全球范围内,人类血吸虫病仍然是一个严重的公共卫生问题,威胁着78个国家的约8亿人,导致7000万伤残调整生命年的损失。日本血吸虫是中国唯一存在的人体血吸虫。作为深受血吸虫病困扰的国家之一,在过去65年里,中国在控制血吸虫病方面取得了巨大进展,阻断了日本血吸虫在五个省份的传播,显著降低了其他七个流行省份的传播强度,中国目前正准备在2025年前朝着消除这种疾病迈进。然而,在通往消除血吸虫病的道路上,新出现的挑战值得关注,包括严重的晚期病例、人口和牲畜流动增加、中间宿主蜗牛大面积分布、新药开发的局限性和无可用疫苗,以及输入性血吸虫病及其潜在风险。